Solving neurodegeneration: common mechanisms and strategies for new treatmentsLauren K. Wareham, David J. Calkins|Molecular Neurodegeneration|2022Cited by 297
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During GlaucomaMichael L. Risner, David J. Calkins|Molecular Neurobiology|2022Cited by 33
Towards A Microbead Occlusion Model of Glaucoma for a Non-Human PrimateWendi S. Lambert, David J. Calkins|Scientific Reports|2019Cited by 32
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of GlaucomaWendi S. Lambert, David J. Calkins|Frontiers in Neuroscience|2017Cited by 30
Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental GlaucomaWendi S. Lambert, David J. Calkins|Scientific Reports|2020Cited by 21